Biodefense is traditionally a term associated with defensive measures taken against biological attack. Dr Michael Kurilla, Director, Office of BioDefense Research Affairs & Associate Director for BioDefense Product Development, DMID, NIAID, NIH, DHHS, spoke at the World Vaccine Congress 2012 in Washington on the application of biodefense to existing vaccines to prevent the potential impact from future pandemics. The necessity for effective preparation has been made clear as historically the impact of biological events has been severe, for example, the 1918 influenza outbreak caused 50-100 million deaths worldwide.
Dr Kurilla spoke about the application of biodefense to vaccines and how this could enhance vaccination technologies. He outlined the current development path and NIH scientific activities in this area of research.
Why not download the full presentation and discover more about enhancing existing vaccines, developing technologies for biodefense vaccines:
- Vaccination enhancement
- Temperature stability
- Alternative delivery devices